SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) December 05, 2003
STEMCELLS, INC.
| Delaware | 0-19871 | 95-3078125 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
3155 Porter Drive
Palo Alto, California 94304
(Address of principal executive offices, including zip code)
(650) 475-3100
(Registrant’s telephone number, including area code)
| Item 4. Changes in Registrant’s Certifying Accountant | ||||||||
| Signature | ||||||||
Item 4. Changes in Registrant’s Certifying Accountant
New Independent Public Accountants
On December 08, 2003, the Company engaged Grant Thornton LLP as its independent public accountants. The Company’s audit committee and board of directors independently approved resolutions on November 17, 2003 and November 20, 2003, respectively, approving the selection of Grant Thornton LLP.
During the Company’s two most recent fiscal years ended December 31, 2002 and the subsequent interim periods through the engagement of Grant Thornton LLP, the Company has not consulted with Grant Thornton LLP regarding either the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, or any matter that was the subject of a disagreement, within the meaning of Item 304(a)(1)(iv) of Regulation S-K, or a reportable event, as described in the Item 304(a)(1)(v) of Regulation S-K.
2
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| StemCells, Inc. | ||||
| By: | /s/ Martin McGlynn | |||
| Martin McGlynn | ||||
| President and Chief Executive Officer | ||||
Date: December 08, 2003
3